Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2001 | Version v1.0.0
Journal Article Open

Valproate/Lamotrigine and Growth Retardation

Abstract

Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Childrens Hospital, Hamilton, Ontario, Canada.

Files

PNB-15-91-b.pdf
Files (719.2 kB)
Name Size Download all
md5:88b86ecc65bbeedd497baab81fc57c61
719.2 kB Preview Download

Additional details

Created:
March 30, 2023
Modified:
March 30, 2023